ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 277 filers reported holding ICU MED INC in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $14,554,000 | -6.1% | 65,372 | +0.1% | 0.01% | 0.0% |
| Q4 2021 | $15,496,000 | +2.3% | 65,289 | +0.6% | 0.01% | -11.1% |
| Q3 2021 | $15,151,000 | +14.7% | 64,920 | +1.2% | 0.01% | +28.6% |
| Q2 2021 | $13,204,000 | +1.6% | 64,160 | +1.5% | 0.01% | 0.0% |
| Q1 2021 | $12,990,000 | +0.4% | 63,228 | +4.8% | 0.01% | -12.5% |
| Q4 2020 | $12,935,000 | +13.4% | 60,305 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $11,406,000 | -4.6% | 62,407 | -3.8% | 0.01% | -11.1% |
| Q2 2020 | $11,955,000 | -17.9% | 64,861 | -10.1% | 0.01% | -30.8% |
| Q1 2020 | $14,560,000 | +19.5% | 72,162 | +10.8% | 0.01% | +44.4% |
| Q4 2019 | $12,181,000 | +70.5% | 65,099 | +45.4% | 0.01% | +50.0% |
| Q3 2019 | $7,146,000 | -3.8% | 44,777 | +51.8% | 0.01% | 0.0% |
| Q2 2019 | $7,432,000 | +4.2% | 29,502 | -1.0% | 0.01% | 0.0% |
| Q1 2019 | $7,135,000 | +11.6% | 29,813 | +7.1% | 0.01% | 0.0% |
| Q4 2018 | $6,391,000 | -17.7% | 27,832 | +1.3% | 0.01% | -14.3% |
| Q3 2018 | $7,769,000 | -20.7% | 27,477 | -17.6% | 0.01% | -22.2% |
| Q2 2018 | $9,796,000 | +24.6% | 33,359 | +7.1% | 0.01% | +12.5% |
| Q1 2018 | $7,860,000 | +18.2% | 31,141 | +1.2% | 0.01% | +14.3% |
| Q4 2017 | $6,648,000 | +24.1% | 30,779 | +6.8% | 0.01% | +16.7% |
| Q3 2017 | $5,358,000 | +6.5% | 28,832 | -1.1% | 0.01% | 0.0% |
| Q2 2017 | $5,031,000 | +23.3% | 29,163 | +9.2% | 0.01% | 0.0% |
| Q1 2017 | $4,079,000 | +14.1% | 26,715 | +10.1% | 0.01% | +20.0% |
| Q4 2016 | $3,574,000 | -3.4% | 24,256 | -17.1% | 0.01% | -16.7% |
| Q3 2016 | $3,698,000 | +2.8% | 29,263 | -8.2% | 0.01% | 0.0% |
| Q2 2016 | $3,596,000 | -4.5% | 31,891 | -11.8% | 0.01% | 0.0% |
| Q1 2016 | $3,765,000 | +14.3% | 36,163 | +23.8% | 0.01% | 0.0% |
| Q4 2015 | $3,295,000 | +24.0% | 29,213 | +20.4% | 0.01% | +20.0% |
| Q3 2015 | $2,657,000 | +20.2% | 24,267 | +5.0% | 0.01% | +25.0% |
| Q2 2015 | $2,211,000 | +2.0% | 23,113 | -0.7% | 0.00% | 0.0% |
| Q1 2015 | $2,168,000 | +14.3% | 23,274 | +0.5% | 0.00% | 0.0% |
| Q4 2014 | $1,896,000 | +17.0% | 23,154 | -8.3% | 0.00% | 0.0% |
| Q3 2014 | $1,620,000 | +39.9% | 25,237 | +32.5% | 0.00% | +33.3% |
| Q2 2014 | $1,158,000 | +1.1% | 19,042 | -0.4% | 0.00% | 0.0% |
| Q1 2014 | $1,145,000 | -10.5% | 19,126 | -4.8% | 0.00% | 0.0% |
| Q4 2013 | $1,280,000 | -9.7% | 20,087 | -3.7% | 0.00% | -25.0% |
| Q3 2013 | $1,417,000 | -4.0% | 20,859 | +1.9% | 0.00% | 0.0% |
| Q2 2013 | $1,476,000 | – | 20,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |